Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

2.
3.

Increased efficiency of folding and peptide loading of mutant MHC class I molecules.

Beissbarth T, Sun J, Kavathas PB, Ortmann B.

Eur J Immunol. 2000 Apr;30(4):1203-13.

5.

Nucleotide binding by TAP mediates association with peptide and release of assembled MHC class I molecules.

Knittler MR, Alberts P, Deverson EV, Howard JC.

Curr Biol. 1999 Sep 23;9(18):999-1008.

6.

Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP.

Lewis JW, Neisig A, Neefjes J, Elliott T.

Curr Biol. 1996 Jul 1;6(7):873-83.

7.
8.
10.

Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes.

Biddison WE, Turner RV, Gagnon SJ, Lev A, Cohen CJ, Reiter Y.

J Immunol. 2003 Sep 15;171(6):3064-74.

11.

Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.

Weinzierl AO, Rudolf D, Hillen N, Tenzer S, van Endert P, Schild H, Rammensee HG, Stevanović S.

Eur J Immunol. 2008 Jun;38(6):1503-10. doi: 10.1002/eji.200838136.

12.

The major substrates for TAP in vivo are derived from newly synthesized proteins.

Reits EA, Vos JC, Grommé M, Neefjes J.

Nature. 2000 Apr 13;404(6779):774-8.

PMID:
10783892
13.

Post-endoplasmic reticulum rescue of unstable MHC class I requires proprotein convertase PC7.

Leonhardt RM, Fiegl D, Rufer E, Karger A, Bettin B, Knittler MR.

J Immunol. 2010 Mar 15;184(6):2985-98. doi: 10.4049/jimmunol.0900308. Epub 2010 Feb 17.

14.
15.

Interaction of Bap31 and MHC class I molecules and their traffic out of the endoplasmic reticulum.

Abe F, Van Prooyen N, Ladasky JJ, Edidin M.

J Immunol. 2009 Apr 15;182(8):4776-83. doi: 10.4049/jimmunol.0800242.

16.

Tapasin enhances assembly of transporters associated with antigen processing-dependent and -independent peptides with HLA-A2 and HLA-B27 expressed in insect cells.

Lauvau G, Gubler B, Cohen H, Daniel S, Caillat-Zucman S, van Endert PM.

J Biol Chem. 1999 Oct 29;274(44):31349-58.

17.

Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum.

Golovina TN, Wherry EJ, Bullock TN, Eisenlohr LC.

J Immunol. 2002 Mar 15;168(6):2667-75.

18.

Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.

Maeurer MJ, Gollin SM, Storkus WJ, Swaney W, Karbach J, Martin D, Castelli C, Salter R, Knuth A, Lotze MT.

Clin Cancer Res. 1996 Apr;2(4):641-52.

19.

Selective export of HLA-F by its cytoplasmic tail.

Boyle LH, Gillingham AK, Munro S, Trowsdale J.

J Immunol. 2006 Jun 1;176(11):6464-72.

20.

Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport.

Fruci D, Lauvau G, Saveanu L, Amicosante M, Butler RH, Polack A, Ginhoux F, Lemonnier F, Firat H, van Endert PM.

J Immunol. 2003 Mar 15;170(6):2977-84.

Supplemental Content

Support Center